Zura Bio terminates prior Stone Peach/BAFFX17 agreements, issues 8.66M shares to Athanor Capital

Zura Bio Ltd

Terminated Letter Agreements with Stone Peach and BAFFX17; entered new Athanor Agreement on Dec 29, 2025.
Issued 8,657,402 Class A ordinary shares to Athanor; $7.325M upfront fee and $25M milestone payment on change of control or first regulatory approval.
Athanor receives piggyback registration rights and 2% net sales royalty on tibulizumab (ZB-106) from the Lilly license.
Audit Subcommittee review completed; no financial statement impact or employee misconduct found.
New terms deemed more commercially advantageous; prior agreements voided with broad releases.

item 1.01 item 1.02 item 3.02 item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001104659-26-000209
form_type: 8-K
ticker: ZURA
cik: 0001855644
company_name: Zura Bio Ltd
filed_at: 2026-01-02T23:59:59+00:00
discovered_at: 2026-05-14T18:02:36.566253+00:00
generated_at: 2026-05-16T11:50:20.164147+00:00
sec_items: ["1.01", "1.02", "3.02", "8.01", "9.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.75
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001104659-26-000209
json_url: https://secwatch.observer/filing/0001104659-26-000209.json
markdown_url: https://secwatch.observer/filing/0001104659-26-000209.md
text_url: https://secwatch.observer/filing/0001104659-26-000209.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1855644/000110465926000209/0001104659-26-000209-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1855644/000110465926000209/tm2531128d1_8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001104659-26-000209

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.